果酱视频

Clopidogrel moved markedly higher in India during May as strong institutional buying and tighter merchant availability pushed EXW quotations up through the month. Early鈥揗ay saw Jan Aushadhi tenders front-load purchases of Clopidogrel ahead of the monsoon quarter, while mid-month hospital procurement and precautionary stocking by large chains absorbed much of the domestic merchant pool. Meanwhile, Clopidogrel producers ran cautiously following recent US FDA re-inspections, favouring compliant batch sizes over maximum throughput and limiting near-term uplifts in output. Late鈥揗ay export demand for Clopidogrel softened as several international buyers shifted toward lower-priced Chinese supply, but domestic demand channels remained the dominant price driver throughout the month.

Institutional demand proved the principal support for the May advance: government / institutional procurement under Jan Aushadhi expanded coverage to more than *** of retail prescriptions, according to 果酱视频 data, while cardiology clinics reported a *.** year-on-year rise in oral...